Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Zymeworks Inc (ZYME)

Zymeworks Inc (ZYME)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,207,611
  • Shares Outstanding, K 46,554
  • Annual Sales, $ 38,950 K
  • Annual Income, $ -180,550 K
  • 60-Month Beta 1.03
  • Price/Sales 29.57
  • Price/Cash Flow N/A
  • Price/Book 3.56
Trade ZYME with:

Options Overview Details

View History
  • Implied Volatility 88.26%
  • Historical Volatility 66.44%
  • IV Percentile 44%
  • IV Rank 18.98%
  • IV High 158.38% on 01/14/21
  • IV Low 71.83% on 03/18/21
  • Put/Call Vol Ratio 0.82
  • Today's Volume 191
  • Volume Avg (30-Day) 195
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 472
  • Open Int (30-Day) 547

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -1.18
  • Number of Estimates 5
  • High Estimate -1.01
  • Low Estimate -1.38
  • Prior Year -1.43
  • Growth Rate Est. (year over year) +17.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.41 +6.27%
on 10/08/21
37.19 -30.25%
on 09/17/21
-7.09 (-21.47%)
since 09/15/21
3-Month
24.41 +6.27%
on 10/08/21
38.63 -32.85%
on 07/21/21
-9.66 (-27.13%)
since 07/15/21
52-Week
24.41 +6.27%
on 10/08/21
59.03 -56.06%
on 01/12/21
-19.09 (-42.39%)
since 10/15/20

Most Recent Stories

More News
Here's Why Zymeworks Inc. (ZYME) is Poised for a Turnaround After Losing 24.1% in 4 Weeks

Zymeworks Inc. (ZYME) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising...

ZYME : 25.94 (+4.85%)
Zymeworks and ALX Oncology Announce First Patient Dosed in Phase 1b/2 Clinical Trial of Zanidatamab and Evorpacept (ALX148) in Patients with Advanced HER2-Expressing Breast Cancer and Other Solid Tumors

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, and ALX Oncology Holdings Inc. (NASDAQ: ALXO), a clinical-stage immuno-oncology company...

ZYME : 25.94 (+4.85%)
ALXO : 58.99 (-0.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered...

See More

Key Turning Points

3rd Resistance Point 29.15
2nd Resistance Point 28.13
1st Resistance Point 27.03
Last Price 25.94
1st Support Level 24.92
2nd Support Level 23.90
3rd Support Level 22.80

See More

52-Week High 59.03
Fibonacci 61.8% 45.81
Fibonacci 50% 41.72
Fibonacci 38.2% 37.63
Last Price 25.94
52-Week Low 24.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar